# A Study of LY2216684 in Participants With Impaired Hepatic Function

> **NCT01241435** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** LY2216684

## Key facts

- **NCT ID:** NCT01241435
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241435, "A Study of LY2216684 in Participants With Impaired Hepatic Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01241435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*